Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine , Adsorbed

China Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed, Find details about China Dtap from Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed

Pharmaceutical Technology
Chemical Synthesis
Pharmaceutical Technology
Chemical Synthesis

Description

 

Indications

The product can induce immune response in recipients following immunization.

 It is used to prevent diphtheria, tetanus and pertussis.

 

Highlights

1. Similar to Sanofi's Tripacel

2. Acellular pertussis is more safer, less adverse reactions than DTwP

3. Complete phase I, III Clinical Trial in China

4. Being registered in India

 

Dosage form

Freeze-dried powder for Injection

 

Specification

0.5 ml/vial/dose

 

Route of Administration

Intramuscular injection

 

Shelf life

24 Months